Spots Global Cancer Trial Database for Low Dose Radiation to Improve T-Cell Infiltration in Pancreatic Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Low Dose Radiation to Improve T-Cell Infiltration in Pancreatic Cancer
Official Title: Randomised Phase I/II Trial in Order to Evaluate the Effect of Neoadjuvant Radiation on Tumor Infiltrating T-cells by Neoadjuvant Low-Dose-Radiation Therapy in Primarily Resectable Pancreatic Cancer
Study ID: NCT01027221
Conditions
Study Description
Brief Summary: Principal purpose of the study is the determination of an active local external beam radiotherapy dose leading to a maximum number of tumor infiltrating T-cells.
Detailed Description:
Eligibility
Minimum Age: 50 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Clinic for General, Visceral and Transplantation Surgery, Heidelberg, , Germany
German Cancer Research Center, Heidelberg, , Germany
Contact Details
Name: Peter E. Huber, Prof. PhD MD
Affiliation: German Cancer Research Centre and Clinic for Radiation Oncology of the University of Heidelberg
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
